The development came four months after the Drug Controller General of India (DGCI) show caused multiple online pharmacy platforms over the violation of norms regarding the online sale of drugs
Prior to this, Neuberger Berman, a New York-based investment management firm slashed PharmEasy’s valuation by 21 per cent to 4.4 billion as of February 28
